VistaGen Therapeutics (VTGN)

• Market cap: $117M
• 1 day: 0%
• 5 days: -5.24%
• 1 month: -5.24%
• 3 months: 28.38%
• 6 months: 68.14%
• Year to date: 14.46%
• 1 year: 39.19%
• 5 years: -82.5%
• 10 years: -96.92%
• Sector: Healthcare
• Industry: Biotechnology

About: Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Employees: 57